MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹88 Cr | ₹78 Cr | ₹85 Cr | ₹83 Cr | ₹73 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹88 Cr |
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹85 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹73 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹88 Cr | 12.48 | |
| Mar2025 | ₹78 Cr | -7.56 | |
| Mar2024 | ₹85 Cr | 2.40 | |
| Mar2023 | ₹83 Cr | 13.60 | |
| Mar2022 | ₹73 Cr | - | |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹357.8 Cr | -11.4% | -20.6% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -11.4% |
-20.6% |
-15.2% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses